Cargando…

Antipsychotic switching tool [Update]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2019
Materias:	Subscriptions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954871/ https://www.ncbi.nlm.nih.gov/pubmed/31937995 http://dx.doi.org/10.18773/austprescr.2019.072

Ejemplares similares

The Way to Kill Waiting-Lists, and How to Pay for Additional Upkeep
Publicado: (1917)

Antipsychotic switching tool [Update 2]
Publicado: (2020)

Antipsychotic switching tool [Update 3]
Publicado: (2021)

Antipsychotic switching tool [Update 4]
Publicado: (2022)

Antipsychotic switching tool
por: Keks, Nicholas, et al.
Publicado: (2019)

Stopping and switching antipsychotic drugs
por: Keks, Nicholas, et al.
Publicado: (2019)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Pharmacy switch of antipsychotic medications: patient’s perspective
por: Murawiec, Slawomir, et al.
Publicado: (2015)

Clinical pharmacology of atypical antipsychotics: an update
por: Mauri, M.C., et al.
Publicado: (2014)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
por: Faries, Douglas E, et al.
Publicado: (2009)

The Influence of Previous Antipsychotic Polypharmacy Versus Monotherapy on the Effectiveness of Antipsychotic after Switching to Paliperidone Extended-release
por: Lee, Hee-Won, et al.
Publicado: (2013)

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
por: Periclou, Antonia, et al.
Publicado: (2019)

Update on the role of antipsychotics in the treatment of Tourette syndrome
por: Huys, Daniel, et al.
Publicado: (2012)

A case of postpsychotic depression improved by switching antipsychotic monotherapy
por: Oguchi, Yoshiyo, et al.
Publicado: (2022)

Long-acting injectable antipsychotics during pregnancy: An update
por: Paraschakis, A., et al.
Publicado: (2021)

A retrospective study of antipsychotic drug switching in a pediatric population
por: Linton, David, et al.
Publicado: (2013)

Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020)

Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
por: Bak, Maarten, et al.
Publicado: (2021)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

The Effect of Switching to Long-Acting Injection (LAI) Antipsychotic Therapy on Patients with Schizophrenia
por: STRUNOIU, LIVIA MIHAELA, et al.
Publicado: (2021)

Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Cascino, Giammarco, et al.
Publicado: (2022)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review
por: Saber, Wael K, et al.
Publicado: (2022)

Myocarditis in patients on long-term antipsychotics –mechanism, management and recent updates
por: Daniel, Patterson, et al.
Publicado: (2023)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia
por: Noordsy, Douglas L, et al.
Publicado: (2010)

Efficacy and Tolerability of Aripiprazole: A 26-Week Switching Study from Oral Antipsychotics
por: Lee, Jung-Sun, et al.
Publicado: (2010)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
por: Boonlue, Tuanthon, et al.
Publicado: (2016)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

S3. DOES SWITCHING OR AUGMENTING HELP WITH ANTIPSYCHOTIC-RELATED SEXUAL DYSFUNCTION: SYSTEMATIC REVIEW
por: Allen, Kirsty, et al.
Publicado: (2020)

Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review
por: Rajkumar, Ravi Philip
Publicado: (2022)

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics
por: Kwon, Jun Soo, et al.
Publicado: (2015)

Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2019)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics
por: Spark, Daisy L., et al.
Publicado: (2022)

Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
por: Ifteni, Petru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1l4e5fkfr53kufece7g96jlqan